» Articles » PMID: 9356488

T Cell Functions in Granulocyte/macrophage Colony-stimulating Factor Deficient Mice

Overview
Specialty Science
Date 1997 Nov 14
PMID 9356488
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Immunological functions were analyzed in mice lacking granulocyte/macrophage colony-stimulating factor (GM-CSF). The response of splenic T cells to allo-antigens, anti-mouse CD3 mAb, interleukin 2 (IL-2), or concanavalin A was comparable in GM-CSF +/+ and GM-CSF -/- mice. To investigate the responses of CD8(+) and CD4+ T cells against exogenous antigens, mice were immunized with ovalbumin peptide or with keyhole limpet hemocyanin (KLH). Cytotoxic CD8+ T cells with specificity for ovalbumin peptide could not be induced in GM-CSF -/- mice. After immunization with KLH, there was a delay in IgG generation, particularly IgG2a, in GM-CSF -/- mice. Purified CD4+ T cells from GM-CSF -/- mice immunized with KLH showed impaired proliferative responses and produced low amounts of interferon-gamma (IFN-gamma) and IL-4 when KLH-pulsed B cells or spleen cells were used as antigen presenting cells (APC). When enriched dendritic cells (DC) were used as APC, CD4+ T cells from GM-CSF -/- mice proliferated as well as those from GM-CSF +/+ mice and produced high amounts of IFN-gamma and IL-4. To analyze the rescue effect of DC on CD4(+) T cells, supernatants from (i) CD4(+) T cells cultured with KLH-pulsed DC or (ii) DC cultured with recombinant GM-CSF were transferred to cultures of CD4(+) T cells and KLH-pulsed spleen cells from GM-CSF -/- mice. Supernatants from both DC sources contained a factor or factors that restored proliferative responses and IFN-gamma production of CD4(+) T cells from GM-CSF -/- mice.

Citing Articles

Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production.

Lian G, Wang Q, Mak T, Huang X, Yu X, Lan H Cell Mol Life Sci. 2024; 81(1):262.

PMID: 38878186 PMC: 11335298. DOI: 10.1007/s00018-024-05290-4.


A toxicology study of complementation and pulmonary macrophage transplantation therapy of hereditary PAP in mice.

Arumugam P, Carey B, Wikenheiser-Brokamp K, Krischer J, Wessendarp M, Shima K Mol Ther Methods Clin Dev. 2024; 32(2):101213.

PMID: 38596536 PMC: 11001781. DOI: 10.1016/j.omtm.2024.101213.


IFN-γ-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1α.

Van Dis E, Fox D, Morrison H, Fines D, Babirye J, McCann L PLoS Pathog. 2022; 18(7):e1010721.

PMID: 35877763 PMC: 9352196. DOI: 10.1371/journal.ppat.1010721.


GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.

Kumar A, Taghi Khani A, Sanchez Ortiz A, Swaminathan S Front Immunol. 2022; 13:901277.

PMID: 35865534 PMC: 9294178. DOI: 10.3389/fimmu.2022.901277.


An update on GM-CSF and its potential role in melanoma management.

Dillman R Melanoma Manag. 2020; 7(3):MMT49.

PMID: 32922731 PMC: 7475793. DOI: 10.2217/mmt-2020-0011.


References
1.
Park L, Friend D, Gillis S, Urdal D . Characterization of the cell surface receptor for granulocyte-macrophage colony-stimulating factor. J Biol Chem. 1986; 261(9):4177-83. View

2.
Adema G, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S . A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 1997; 387(6634):713-7. DOI: 10.1038/42716. View

3.
Larrick J, Morhenn V, Chiang Y, Shi T . Activated Langerhans cells release tumor necrosis factor. J Leukoc Biol. 1989; 45(5):429-33. DOI: 10.1002/jlb.45.5.429. View

4.
Moore M . The clinical use of colony stimulating factors. Annu Rev Immunol. 1991; 9:159-91. DOI: 10.1146/annurev.iy.09.040191.001111. View

5.
Steinman R . The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991; 9:271-96. DOI: 10.1146/annurev.iy.09.040191.001415. View